Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company is headquartered in Phoenix, Arizona.
| Revenue (TTM) | 6,000 |
| Gross Profit (TTM) | 3,806 |
| EBITDA | $-6.02M |
| Operating Margin | -64859.00% |
| Return on Equity | -86.50% |
| Return on Assets | -53.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.03 |
| Price-to-Book | 1.01 |
| Price-to-Sales (TTM) | 1256.87 |
| EV/Revenue | 63.77 |
| EV/EBITDA | -1.46 |
| Quarterly Earnings Growth (YoY) | 358.90% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.70M |
| Float | $3.43M |
| % Insiders | 0.95% |
| % Institutions | 7.15% |
Volatility is currently expanding